Jake Johnson, Common Dreams ‘Absolute robbery’: Gilead announces $3,120 Price Tag for COVID-19 drug developed with $70 million in taxpayer support

“Taxpayers provided funding for the development of this drug. Now Gilead is price-gouging off it during a pandemic. Beyond disgusting,” said Sen. Bernie Sanders. Consumer advocates reacted with disgust Monday to an announcement by Gilead Sciences that it will charge U.S. hospitals around $3,120 per privately insured patient for a treatment course of remdesivir, a drug which […]Read More

READ ALL ABOUT IT

Spread the word

CoronaNews

Our Power 🦠 in numbers

Stay Safe. Join us to get the latest local Corona Virus news - Every Day.